Agomelatine strongly interacts with zwitterionic DPPC and charged DPPG membranes

2014-11-01
Ergun, Seza
Demir, Pinar
Uzbay, Tayfun
Severcan, Feride
Show full item record
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
140
views
0
downloads
Depression is one of the most common psychiatric diseases in the population. Agomelatine is a novel antidepressant drug with melatonin receptor agonistic and serotonin 5-HT2C antagonistic properties. Furthermore, being a melatonergic drug, agomelatine has the potential of being used in therapeutic applications like melatonin as an antioxidant, anti-inflammatory and antiapoptotic drug. The action mechanism of agomelatine on the membrane structure has not been clarified yet. In the present study, we aimed to investigate the interaction of agomelatine with model membranes of dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylgylcerol (DPPG) by Fourier transform infrared (FTIR) spectroscopy and differential scanning calorimetry (DSC). We found that agomelatine interacts with the head group in such a manner that it destabilizes the membrane architecture to a large extent. Thus, agomelatine causes alterations in the order, packing and dynamics of the DPPC and DPPG model membranes. Our results suggest that agomelatine strongly interacts with zwitterionic and charged membrane phospholipids. Because lipid structure and dynamics may have influence on the structure of membrane bound proteins and affect the signal transduction systems of membranes, these effects of agomelatine may be important in its action mechanism.
Agomelatine, Membrane lipid, FTIR spectroscopy, DSC, Lipid structure
https://hdl.handle.net/11511/51122
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
Department of Biology, Article

Suggestions

Structural and functional investigation of the interaction of agomelatine with model membranes
Ergün, Seza; Severcan, Feride; Department of Biology (2012)
Depression is one of the most commonly seen psychiatric diseases in the population in recent years. Treatment of depression is mainly carried out by psychiatric drugs. In the past few years, agomelatine which is released to the market with a trade name, Valdoxane, has been thought to have far less side effects due to its non-addictive nature, not having trouble when the drug is quitted, and also due to its property of binding only to the specific receptor that the drug interacts with. The action mechanism o...
Fluoxetine, not donepezil, reverses anhedonia, cognitive dysfunctions and hippocampal proteome changes during repeated social defeat exposure
Gottschalk, M. G.; Mortas, P.; Haman, M.; Özcan Kabasakal, Süreyya; Biemans, B.; Bahn, S. (Elsevier BV, 2018-01-01)
While anhedonia is considered a core symptom of major depressive disorder (MDD), less attention has been paid to cognitive dysfunctions. We evaluated the behavioural and molecular effects of a selective serotonin re-uptake inhibitor (SSRI, fluoxetine) and an acetylcholinesterase inhibitor (AChEI, donepezil) on emotional-cognitive endophenotypes of depression and the hippocampal proteome. A chronic social defeat (SD) procedure was followed up by "reminder" sessions of direct and indirect SD. Anhedonia-relate...
The Impact of COVID-19 on the People with Mental Illnesses: Health Anxiety, Coping Strategies, and Psychological Well-Being
Karaköse, Selin (ODTÜ- AYNA Klinik Psikoloji Destek Ünitesi, 2022-10)
Although depression, anxiety, and stress were highly prevalent in the general population during the pandemic, some marginalized groups, including patients with mental disorders might have been overlooked in studies. This study examined the relationship between health anxiety, coping strategies, and mental health outcomes, particularly depressive symptoms, anxiety, and stress. The aim of the current study is to examine the mediator role of coping strategies between health anxiety and mental health outcomes i...
Shame Experiences Underlying Depression of Adult Turkish Women
Sari, Sevda; Gençöz, Faruk (2016-07-01)
Shame is a major component of many mental health problems and affects symptoms, coping styles, remission, and therapeutic ruptures. There are few qualitative studies aimed at understanding shame and its role for patients diagnosed with depression. In this research, we explored the origins of shame, and the coping strategies that patients diagnosed with depression employ to cope with shame. This qualitative research aimed at an in-depth analysis of shame experiences of adult women who had been diagnosed with...
Effective connectivity model differences of emotion regulation in major depressive disorder: dynamic causal modeling analysis
Özaydın, Mustafa; Çakır, Murat Perit; Department of Cognitive Sciences (2021-9)
Major Depressive Disorder (MDD) is a mental disorder and one of the most critical and prevalent disorders in the world. Unlike other diseases, the diagnosis of mental disorders does not easily conform to objective tests. Medical experts consider several indicators to be able to distinguish a depressed person from a normal individual, and finding robust markers to aid diagnosis is still an active area of research. The recent proliferation of neuroimaging methods has brought up new opportunities in that regar...
Citation Formats
S. Ergun, P. Demir, T. Uzbay, and F. Severcan, “Agomelatine strongly interacts with zwitterionic DPPC and charged DPPG membranes,” BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, pp. 2798–2806, 2014, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/51122.
METU IIS - Integrated Information Service open@metu.edu.tr